Although the Centers for Disease Control and Prevention is working with state, local and territorial public health departments on following pregnant women who have laboratory evidence of Zika virus infection, the agency acknowledges that it needs to do a better job tracking infant outcomes.
“We gather data on evaluations that are done on the mother and fetus throughout pregnancy and, importantly, also on the condition of the fetus and medical consequences of infection following birth,” Lyle Petersen, MD, director of the Division of Vector-Borne Diseases in the CDC’s National Center for Emerging and Zoonotic Infectious Diseases, told a House subcommittee on Tuesday. “What we know now is that some of the babies that may appear completely normal actually aren’t.”
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access